Fenofibrate
Product Images NDC 70934-224

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 70934-224). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 224 30 Rev A 01 19)

Fenofibrate Tablets USP 145 mg, 30 count bottle label by Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The label includes the NDC 70934-224-30, dosage instructions to see package insert, storage instructions at 20°-25°C, and warnings to keep out of reach of children and protect from moisture. It also states the tablets are film-coated and repackaged by Northwind Pharmaceuticals in New York.*

FDA Label Image

Structural Formula (Image 01)

Chemical structure of fenofibrate, showing its molecular formula with chlorophenyl and ester functional groups connected by a carbonyl and ether linkage.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.